National Bank of Canada’s Cellectis CLLS Stock Holding History

National Bank of Canada’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.1K	Hold	3,600	–	–	﹤0.01%	2309
2025 Q4	$17.2K	Hold	3,600	–	–	﹤0.01%	2188
2025 Q3	$10.1K	Hold	3,600	–	–	﹤0.01%	2318
2025 Q2	$5.4K	Hold	3,600	–	–	﹤0.01%	2478
2025 Q1	$4.43K	Hold	3,600	–	–	﹤0.01%	2397
2024 Q4	$6.48K	Hold	3,600	–	–	﹤0.01%	2409
2024 Q3	$7.63K	Hold	3,600	–	–	﹤0.01%	2135
2024 Q2	$6.88K	Hold	3,600	–	–	﹤0.01%	2207
2024 Q1	$10.8K	Hold	3,600	–	–	﹤0.01%	2159
2023 Q4	$11K	Hold	3,600	–	–	﹤0.01%	2148
2023 Q3	$5.35K	Hold	3,600	–	–	﹤0.01%	2332
2023 Q2	$7.01K	Hold	3,600	–	–	﹤0.01%	2271
2023 Q1	$6.95K	Hold	3,600	–	–	﹤0.01%	2228
2022 Q4	$7.45K	Hold	3,600	–	–	﹤0.01%	2249
2022 Q3	$8K	Hold	3,600	–	–	﹤0.01%	2235
2022 Q2	$10K	Buy	+3,600	New	+$12.7K	﹤0.01%	2260

Other funds holding CLLS

BGI

B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

National Bank of Canada's CLLS Position: Q1 2026 in Review

National Bank of Canada held its Cellectis (CLLS) position steady in Q1 2026 at 3,600 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2309.

National Bank of Canada first reported a position in CLLS in Q2 2022 and has held it in 16 quarters since. The position peaked at $17.2K in Q4 2025. 32 funds tracked by Wall St. Rank hold CLLS as of Q1 2026.

National Bank of Canada held 3,600 shares of Cellectis worth $11.1K as of Q1 2026.
National Bank of Canada left its Cellectis share count unchanged in Q1 2026.
Cellectis made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2309 holding.
National Bank of Canada first reported a position in Cellectis in Q2 2022 and has held it in 16 quarters since.
National Bank of Canada's Cellectis position peaked at $17.2K in Q4 2025.
32 funds tracked by Wall St. Rank held Cellectis as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.